News

Single-use, 2-channel wearable Biosensor, patient-facing app and cloud-based system enable final Holter reports in hours—not days.

Milpitas, California, USA. January 10, 2025:  LifeSignals, Inc. today announced that the UbiqVueTM Multiparameter System will be presented at Arab Health 2025, 27th – 30th January in Dubai, UAE. The end-to-end wireless system, with FDA 510(k) clearance and MDR Certification, represents a significant milestone in advancing continuous patient monitoring for population health management. UbiqVue Multiparameter …

LifeSignals Showcases UbiqVue Multiparameter System at Arab Health 2025 Read More »

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO₂, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings

• Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring
• Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care
• Developed to support scalable population health management
• Follows FDA 510(k) Clearance

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO₂, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings

• Replaces time-consuming manual spot checking with continuous, near real-time active patient monitoring
• Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care
• Developed to support scalable population health management

Further validation of ability to deliver continuous remote patient vital signs monitoring within both hospital and home settings.

LifeSignals receives CE Mark Approval for LifeSignals LX1550E Multiparameter Remote Monitoring Platform. Enables healthtech partners to deliver continuous remote patient vital signs monitoring within hospital and home settings.

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World’s first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings

Continuous patient monitoring with remote data access in ambulatory, hospital and home settings enables faster clinical decision making

LifeSignals accelerates introduction of single-use wireless medical biosensor patches for COVID-19 mass population remote monitoring

LifeSignals receives HSA clearance for Tripatch™ ECG Remote Monitoring Biosensor Platform (LX1250) in Singapore